Listed

Thermo Fisher Scientific Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Feb 25, 2016 and accepted by EDGAR at Feb 25, 2016, 14:24 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-09-27 to 2015-12-31$4.65bnus-gaap:Revenues
Revenue12 months2015-01-01 to 2015-12-31$16.97bnus-gaap:Revenues
Cost of revenue12 months2015-01-01 to 2015-12-31$7.58bnus-gaap:CostOfGoodsSold
Gross profit3 months2015-09-27 to 2015-12-31$2.11bnus-gaap:GrossProfit
Research and development12 months2015-01-01 to 2015-12-31$692.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2015-01-01 to 2015-12-31$4.61bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2015-01-01 to 2015-12-31$2.34bnus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31$414.9mus-gaap:InterestExpense
Income tax12 months2015-01-01 to 2015-12-31−$43.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-09-27 to 2015-12-31$602.6mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income12 months2015-01-01 to 2015-12-31$1.98bnus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2015-09-27 to 2015-12-31$1.50us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31$4.92us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-09-27 to 2015-12-31$1.51us-gaap:EarningsPerShareBasic
Basic EPS12 months2015-01-01 to 2015-12-31$4.96us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2015-01-01 to 2015-12-31401,900,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2015-01-01 to 2015-12-31$2.82bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2015-01-01 to 2015-12-31$422.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2015-01-01 to 2015-12-31$240.6mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases12 months2015-01-01 to 2015-12-31$500.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-12-31$452.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$5.74bnus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$40.89bnus-gaap:Assets
Current liabilitiesAt period end2015-12-31$4.15bnus-gaap:LiabilitiesCurrent
Current portion of debtAt period end2015-12-31$1.05bnus-gaap:DebtCurrent
Short-term borrowingsAt period end2015-12-31$50.0mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2015-12-31$21.35bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000097745-16-000043. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.